Advances in Care NewYork-Presbyterian

Since its inception, the lung transplant program at NewYork-Presbyterian and Columbia has seen more than 1,600 patients receive organs. But, as one of the oldest and most experienced centers in the world, this did not come without some challenges. In the late 1980s, access to donor lungs was extremely limited which made transplanting patients difficult. Once joining the program in 2001, Dr. Selim Arcasoy and his team had a vision to change that. Over the course of two decades, the lung transplant team has been dedicated to building a robust program that utilizes years of experience and the latest tools to ensure that even the sickest patients have the opportunity to receive lung transplants.

Hodgkin Lymphoma is the most common cancer type in adolescents and young adults. But until recently, very little was known about the biology of the disease. Enter, Dr. Lisa Roth, Director of Pediatric Oncology at NewYork Presbyterian and Weill Cornell Medicine, and her team of researchers. Their tireless work to pin down the difficult biology of Hodgkin Lymphoma has led them to became the first scientists to map the entire Hodgkin Lymphoma genome, uncovering new pathways to treat this historically understudied cancer-type.

Over the years working in the neurocritical ICU, Dr. Soojin Park recognized a problem: She knew that 30 to 40% of her patients were at risk for stroke in the weeks following an aneurysmal subarachnoid hemorrhage, but it was still difficult to determine which patients were most likely to develop additional problems, like a delayed cerebral ischemia, and treat them accordingly. So, Dr. Park used her background in data science to develop a tool that can better predict which specific patients were at increased risk. The COSMIC score utilizes machine learning, and basic patient data such as blood pressure and heart rate, to predict likely outcomes, and improve targeted patient care in the neurocritical ICU.

By the year 2030, there will be around 22 million cancer survivors. And while cancer treatment continues to improve, it’s an unfortunate reality that many of these patients are at increased risk for cardiovascular issues, because of biology or as a byproduct of their life saving treatments. But recently, the field of cardio-oncology has emerged to help cancer patients minimize short and long term risks to their hearts. Dr. Stephanie Feldman speaks about the research pushing this innovative field forward and how it will increase the quality of life for so many patients in the years to come.

Dr. Jason Hawksworth, Dr. Tamatha Fenster, and Dr. Arnar Geirsson come from different specialties, but one thing unites them: the implementation of surgical robotics to advance their practices. In this episode, the doctors discuss how robots are revolutionizing the fields of hepatobiliary, gynecological, and cardiac surgeries–and what’s coming next for the future of medicine.

Dr. Robert Christian and Dr. Samuel Van de Velde are orthopedic surgeons with two different specializations, but one common goal: alleviating pain and preserving their patient’s native hip function for as long as possible. With Dr. Christian’s sports medicine and arthroscopic surgery background, and Dr. Van de Velde’s expertise in periacetabular Ganz osteotomy, the uniquely qualified pair run a combination clinic focused on hip preservation - one of few in the country to offer this type of collaborative treatment approach.